A. Amirkhosravi

发表

CD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice.

T. Meyer, L. Robles-Carrillo, M. Dávila, 2015, Blood.

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

A. Lawson, Y. Hsu, L. Burkly, 2015, Arthritis Research & Therapy.

Contribution of surface localization to platelet activation by CD154 antibodies and introduction of a novel approach for studying immune complex activity.

T. Meyer, L. Robles-Carrillo, J. Francis, 2011, Thrombosis research.

Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity

A. Krüger, S. Sperl, J. Stürzebecher, 2005, Thrombosis and Haemostasis.

Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study

C. Bokemeyer, M. Dávila, J. Francis, 2015, Experimental Hematology & Oncology.

Microparticle association and heterogeneity of tumor‐derived tissue factor in plasma: is it important for coagulation activation?

I. Sargent, V. Bogdanov, L. Robles-Carrillo, 2014, Journal of thrombosis and haemostasis : JTH.

Assessment of protein C anticoagulant pathway by thrombin generation assay in the presence of endothelial cells

L. Robles-Carrillo, J. Francis, A. Amirkhosravi, 2012, Journal of thrombosis and haemostasis : JTH.

Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis.

F. Siddiqui, J. Biggerstaff, T. Meyer, 1999, Platelets.

Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class

L. Audoly, A. Skerra, M. Hülsmeyer, 2015, Angiogenesis.

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

T. Meyer, L. Robles-Carrillo, M. Dávila, 2009, Journal of thrombosis and haemostasis : JTH.

Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis.

S. Mousa, T. Meyer, M. Dávila, 2010, Methods in molecular biology.

Tissue Factor-Bearing Microparticles Derived from Tumor Cells: Impact on Coagulation Activation.

M. Dávila, J. Francis, A. Amirkhosravi, 2006 .

Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses

G. Bigsby, T. Meyer, L. Robles-Carrillo, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454

S. Mousa, T. Meyer, H. Desai, 2003, Thrombosis and Haemostasis.

A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity

H. Wong, J. Weidanz, Javier Hernández, 2004, Cancer Immunology, Immunotherapy.

Deficiencies in the CD40 and CD154 receptor-ligand system reduce experimental lung metastasis

T. Meyer, H. Desai, J. Francis, 2009, Clinical & Experimental Metastasis.

Hemostasis and Malignancy

J. Biggerstaff, J. Francis, A. Amirkhosravi, 1998, Seminars in thrombosis and hemostasis.

Experimental metastasis and primary tumor growth in mice with hemophilia A

C. Bokemeyer, B. Eifrig, A. Amirkhosravi, 2006, Journal of thrombosis and haemostasis : JTH.

An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF

D. Hossfeld, S. Loges, W. Fiedler, 2004, Thrombosis and Haemostasis.

The presence and release of tissue factor from human platelets

F. Siddiqui, H. Desai, J. Francis, 2002, Platelets.

Antimetastatic effect of tinzaparin, a low‐molecular‐weight heparin

S. Mousa, J. Francis, A. Amirkhosravi, 2003, Journal of thrombosis and haemostasis : JTH.

The role of CD40 in CD40L- and antibody-mediated platelet activation

F. Siddiqui, Sarfraz Ahmad, T. Meyer, 2005, Thrombosis and Haemostasis.

Human platelets contain and release TWEAK

T. Meyer, L. Robles-Carrillo, H. Desai, 2010, Platelets.

Anti-CD40L Immune Complexes Potently Activate Platelets In Vitro and Cause Thrombosis in FCGR2A Transgenic Mice

Y. Hsu, E. Garber, T. Meyer, 2010, The Journal of Immunology.

Targeting Angiogenesis in Cancer: Bevacizumab-Induced Platelet Activation as a Possible Cause for Unexpected Arterial Thromboembolic Events in Clinical Trials.

T. Meyer, H. Desai, J. Francis, 2006 .

Hemoglobin enhances tissue factor expression on human malignant cells

F. Siddiqui, J. Biggerstaff, T. Meyer, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Platelet–CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity

A. Amirkhosravi, J. Francis, M. Amaya, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin

S. Mousa, R. Linhardt, J. Francis, 2006, Thrombosis and Haemostasis.

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

G. Yancopoulos, N. Stahl, N. Papadopoulos, 2016, Angiogenesis.

The Importance of Platelets in the Expression of Monocyte Tissue Factor Antigen Measured by a New Whole Blood Flow Cytometric Assay

G. Warnes, J. Biggerstaff, A. Amirkhosravi, 1996, Thrombosis and Haemostasis.

Prospective Evaluation of Laboratory Tests for the Diagnosis of Heparin-Induced Thrombocytopenia.

T. Meyer, H. Desai, J. Francis, 2006 .

Tissue Factor Pathway Inhibitor Reduces Experimental Lung Metastasis of B16 Melanoma

F. Siddiqui, T. Meyer, H. Desai, 2002, Thrombosis and Haemostasis.

Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice.

Lei Zhao, Jeffrey W Pollard, J. Pollard, 2012, Blood.

Tissue factor‐bearing microparticles derived from tumor cells: impact on coagulation activation

J. Colon, C. Baker, M. Dávila, 2008, Journal of thrombosis and haemostasis : JTH.

The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse Neuro2a neuroblastoma

G. Warnes, J. Biggerstaff, J. Francis, 1997, Clinical & Experimental Metastasis.

The role of tissue factor pathway inhibitor in tumor growth and metastasis.

Shaker A Mousa, S. Mousa, Ali Amirkhosravi, 2007, Seminars in thrombosis and hemostasis.

In Vitro and In Vivo Characterization of a Novel Antibody-Like Single-Chain TCR Human IgG1 Fusion Protein1

Xiaoyun Zhu, John L. Francis, H. Wong, 2005, The Journal of Immunology.

Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer

C. Bokemeyer, F. Chun, M. Rink, 2009, Thrombosis and Haemostasis.

Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers

C. Bokemeyer, F. Chun, B. Eifrig, 2007, Thrombosis and Haemostasis.

Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis

F. Siddiqui, J. Biggerstaff, S. Fogarty, 2004, Clinical & Experimental Metastasis.

Fibrin monomer increases platelet adherence to tumor cells in a flowing system: a possible role in metastasis?

J. Biggerstaff, T. Meyer, J. Francis, 1998, Thrombosis research.

An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors.

John Francis, P. Parren, S. Verploegen, 2014, Cancer research.

Reducing Cardiovascular Risk in Women With Lupus: Perception of Risk and Predictors of Risk-Reducing Behaviors

K. Dennis, Patricia K. Weinstein, T. Angelopoulos, 2014, The Journal of cardiovascular nursing.

Determination of tumor cell procoagulant activity by Sonoclot analysis in whole blood.

G. Warnes, J. Biggerstaff, J. Francis, 1996, Thrombosis research.

Potent Therapeutic Activity against a Broad Range of Solid Tumors Drug Conjugate That Targets Tissue Factor Exhibits

P. Parren, S. Verploegen, W. Bleeker, 2014 .

Therapeutics , Targets , and Chemical Biology An Antibody – Drug Conjugate That Targets Tissue Factor ExhibitsPotent TherapeuticActivity against aBroadRangeof Solid Tumors

P. Parren, S. Verploegen, W. Bleeker, 2014 .

Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.

C. Bokemeyer, N. Mackman, S. Mahner, 2016, Thrombosis research.

CalDAG‐GEFI deficiency protects mice from FcγRIIa‐mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes

W. Bergmeier, T. Meyer, L. Robles-Carrillo, 2014, Journal of thrombosis and haemostasis : JTH.

β2-Glycoprotein 1 Antibodies Directly Activate the Platelet IgG Receptor, FcγRIIa, and Cause Thrombosis in FCGR2A Transgenic but Not in Wild Type Mice

T. Meyer, L. Robles-Carrillo, H. Desai, 2012 .

Aprotinin‐associated hemolytic thrombotic microangiopathy in a patient with acute myelogenous leukemia (AML) and systemic coagulopathy

C. Bokemeyer, T. Brümmendorf, B. Eifrig, 2007, American journal of hematology.

Effect of Antihemostatic Agents on Experimental Tumor Dissemination

J. Francis, A. Amirkhosravi, 2002, Seminars in thrombosis and hemostasis.

Pentoxifylline Inhibits Hypoxia-induced Upregulation of Tumor Cell Tissue Factor and Vascular Endothelial Growth Factor

F. Siddiqui, G. Warnes, J. Biggerstaff, 1998, Thrombosis and Haemostasis.

Enumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy

B. Weidow, J. Biggerstaff, A. Amirkhosravi, 2006, BMC Immunology.

Purification and Properties of Human Melanoma Cell Tissue Factor

F. Siddiqui, T. Meyer, H. Desai, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

T. Meyer, L. Robles-Carrillo, A. Amirkhosravi, 2009, Journal of thrombosis and haemostasis : JTH.

Three-dimensional visualization and quantitation of fibrin in solid tumors by confocal laser scanning microscopy.

J. Biggerstaff, A. Amirkhosravi, J. Francis, 1997, Cytometry.

Recruitment of Monocytes/macrophages by Tissue Factor-mediated Coagulation Is Essential for Metastatic Cell Survival and Premetastatic Niche Establishment in Mice Tissue Factor (tf) Expression by Tumor Cells Correlates with Metastasis Clinically and Supports Metastasis in Experimental Settings. Howe

R. Muschel, J. Im, A. Amirkhosravi, 2022 .